Catenae Innov. PLC - Pilot Agreement

Catenae Innovation PLC
("Catenae", the "Company" or the "Group")
Catenae secures new pilot agreement for Covid-19 testing platform
Catenae Innovation PLC (AIM: CTEA), the AIM quoted provider of digital media and technology, is pleased to announce that a Fortune 500 American professional services and construction company (the "Client") listed on the New York Stock Exchange is piloting the Company's Covid-19 testing platform across certain areas of its
Upon completion of a Covid-19 test supplied and administered by BHA-Medical Limited, Catenae will securely process the Client's employees' test results on its GDPR-compliant data management platform. The Company will send the test results to each employee by text message and email, and will also provide the Client with details of its employees' results in a daily report in a GDPR-compliant manner.
All results will be fed into Public Health England's database for use by the NHS' Test and Trace service.
The pilot commenced on
"Our platform helps them maintain operational effectiveness as best they can in the current circumstances through having up-to-date test result information about the Covid-19 health status of their working populations wherever they are.
"The construction industry remains a key target for the Company as it is one of the critical infrastructure sectors that remains operational during the government lockdown. We look forward to updating the market on further progress in due course."
-Ends-
For further information please contact:
Catenae Innovation PLC | +44 (0)191 580 8545 |
| |
Brandon Hill Capital Limited, Broker | +44 (0)20 3463 5000 |
| |
| |
Yellow Jersey PR (PR & IP) | +44 (0)20 3004 9512 |
| |
Notes to Editors:
About Catenae Innovation PLC
Catenae Innovation is an AIM quoted provider of digital media and technology services. Catenae use the power of blockchain to deliver solutions where its people-centric technology enables trust and certainty allowing organisations to gain better control over their operations, manage staff and safely welcome customers.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Quick facts: Catenae Innovation PLC
Price: 3.3
Market: AIM
Market Cap: £9.03 m
Follow
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
FOR OUR FULL DISCLAIMER CLICK HERE